Medios AG (ILM1k)

Currency in EUR
13.1800
0.0000(0.00%)
Delayed Data·
ILM1k is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.040013.2600
52 wk Range
11.120017.4400
Key Statistics
Bid/Ask
13.14 / 13.20
Prev. Close
13.18
Open
13.12
Day's Range
13.04-13.26
52 wk Range
11.12-17.44
Volume
12.21K
Average Volume (3m)
79.96K
1-Year Change
9.8662%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ILM1k Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
23.0000
Upside
+74.51%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Medios AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 23.0000
(+74.51% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Berenberg
Buy26.00+97.27%27.00MaintainMar 30, 2026

Earnings

Latest Release
May 12, 2026
EPS / Forecast
-- / --
Revenue / Forecast
527.6M / --
EPS Revisions
Last 90 days

ILM1k Income Statement

Compare ILM1k to Peers and Sector

Metrics to compare
ILM1k
Peers
Sector
Relationship
P/E Ratio
23.2x14.2x−0.5x
PEG Ratio
−4.030.260.00
Price/Book
0.6x1.8x2.6x
Price / LTM Sales
0.2x1.0x3.1x
Upside (Analyst Target)
84.6%24.8%54.0%
Fair Value Upside
Unlock20.5%6.5%Unlock

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.

Employees
868
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.15M21.03%67.92M
Other Institutional Investors
19.17M78.22%252.65M
Public Companies & Retail Investors
183.21K0.75%2.41M
Total
24.51M100.00%322.99M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BMSH GmbH20.45%5,011,62766,053
Luxempart15.72%3,851,36450,761

People Also Watch

64.300
NEKG
-1.38%
59.90
ADNGk
-0.50%
71.500
SIXG
-0.42%
44.300
FIEG
+0.11%
139.00
SOPR
+0.80%

FAQ

What Is the Medios AG (ILM1k) Stock Price Today?

The Medios AG stock price today is 13.1800 EUR.

What Stock Exchange Does Medios AG Trade On?

Medios AG is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Medios AG?

The stock symbol for Medios AG is "ILM1k."

What Is the Medios AG Market Cap?

As of today, Medios AG market cap is 322.9900M EUR.

What Is Medios AG's Earnings Per Share (TTM)?

The Medios AG EPS (TTM) is 0.5573.

When Is the Next Medios AG Earnings Date?

Medios AG will release its next earnings report on Aug 12, 2026.

From a Technical Analysis Perspective, Is ILM1k a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medios AG Stock Split?

Medios AG has split 4 times.

How Many Employees Does Medios AG Have?

Medios AG has 868 employees.

What is the current trading status of Medios AG (ILM1k)?

As of May 21, 2026, Medios AG (ILM1k) is trading at a price of 13.1800 EUR, with a previous close of 13.1800 EUR. The stock has fluctuated within a day range of 13.0400 EUR to 13.2600 EUR, while its 52-week range spans from 11.1200 EUR to 17.4400 EUR.

What Is Medios AG (ILM1k) Price Target According to Analysts?

The average 12-month price target for Medios AG is 23.0000 EUR, with a high estimate of 26 EUR and a low estimate of 18 EUR. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +74.51% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.